BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 17659930)

  • 1. Baseline predictors of cardiac events after cardiac resynchronization therapy in patients with heart failure secondary to ischemic or nonischemic etiology.
    Soliman OI; Theuns DA; ten Cate FJ; Anwar AM; Nemes A; Vletter WB; Jordaens LJ; Geleijnse ML
    Am J Cardiol; 2007 Aug; 100(3):464-9. PubMed ID: 17659930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cardiac resynchronization therapy on left ventricular diastolic filling pattern in responder and nonresponder patients.
    Agacdiken A; Vural A; Ural D; Sahin T; Kozdag G; Kahraman G; Bildirici U; Ural E; Komsuoglu B
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):654-60. PubMed ID: 16008800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of usefulness of left ventricular diastolic versus systolic function as a predictor of outcome following primary percutaneous coronary angioplasty for acute myocardial infarction.
    Naqvi TZ; Padmanabhan S; Rafii F; Hyuhn HK; Mirocha J
    Am J Cardiol; 2006 Jan; 97(2):160-6. PubMed ID: 16442355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).
    Sutton MG; Plappert T; Hilpisch KE; Abraham WT; Hayes DL; Chinchoy E
    Circulation; 2006 Jan; 113(2):266-72. PubMed ID: 16401777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
    Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
    J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reference ranges for tissue Doppler measures of maternal systolic and diastolic left ventricular function.
    Bamfo JE; Kametas NA; Nicolaides KH; Chambers JB
    Ultrasound Obstet Gynecol; 2007 Apr; 29(4):414-20. PubMed ID: 17330924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are left ventricular diastolic function and diastolic asynchrony important determinants of response to cardiac resynchronization therapy?
    Yu CM; Zhang Q; Yip GW; Chan YS; Lee PW; Wu LW; Lam YY; Kum LC; Chan HC; Chan S; Fung JW
    Am J Cardiol; 2006 Oct; 98(8):1083-7. PubMed ID: 17027576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ischemic etiology of heart failure in diabetics limits reverse left ventricular remodeling after cardiac resynchronization therapy.
    Soliman OI; van Dalen BM; Theuns DA; ten Cate FJ; Nemes A; Jordaens LJ; Geleijnse ML
    J Diabetes Complications; 2009; 23(5):365-70. PubMed ID: 18572420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental value of measuring the time difference between onset of mitral inflow and onset of early diastolic mitral annulus velocity for the evaluation of left ventricular diastolic pressures in patients with normal systolic function and an indeterminate E/E'.
    Min PK; Ha JW; Jung JH; Choi EY; Choi D; Rim SJ; Jang Y; Shim WH; Cho SY; Chung N
    Am J Cardiol; 2007 Jul; 100(2):326-30. PubMed ID: 17631092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure.
    Porciani MC; Macioce R; Demarchi G; Chiostri M; Musilli N; Cappelli F; Lilli A; Ricciardi G; Padeletti L
    Eur J Echocardiogr; 2006 Jan; 7(1):31-9. PubMed ID: 16378918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Good prognostic value of the intraoperative tissue Doppler-derived index E/e' after non-cardiac surgery.
    Cabrera Schulmeyer MC; Arriaza N
    Minerva Anestesiol; 2012 Sep; 78(9):1013-8. PubMed ID: 22699700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volume loading-related changes in tissue Doppler images derived from the tricuspid valve annulus in dogs.
    Hori Y; Ukai Y; Hoshi F; Higuchi S
    Am J Vet Res; 2008 Jan; 69(1):33-8. PubMed ID: 18167084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Load-independent parameters of diastolic and systolic function by speckle tracking and tissue doppler in hemodialysis patients.
    Mendes L; Ribeiras R; Adragão T; Lima S; Horta E; Reis C; Amaral T; Aguiar C; Gouveia R; Silva A
    Rev Port Cardiol; 2008 Sep; 27(9):1011-25. PubMed ID: 19044173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diastolic filling pattern and left ventricular diameter predict response and prognosis after cardiac resynchronisation therapy.
    Gradaus R; Stuckenborg V; Löher A; Köbe J; Reinke F; Gunia S; Vahlhaus C; Breithardt G; Bruch C
    Heart; 2008 Aug; 94(8):1026-31. PubMed ID: 17984216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic heart failure patients with restrictive LV filling pattern have significantly less benefit from cardiac resynchronization therapy than patients with late LV filling pattern.
    Salukhe TV; Francis DP; Clague JR; Sutton R; Poole-Wilson P; Henein MY
    Int J Cardiol; 2005 Apr; 100(1):5-12. PubMed ID: 15820279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of tissue Doppler imaging in patients with chronic congestive heart failure.
    Acil T; Wichter T; Stypmann J; Janssen F; Paul M; Grude M; Scheld HH; Breithardt G; Bruch C
    Int J Cardiol; 2005 Aug; 103(2):175-81. PubMed ID: 16080977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failure.
    Mangiavacchi M; Gasparini M; Faletra F; Klersy C; Morenghi E; Galimberti P; Genovese L; Regoli F; De Chiara F; Bragato R; Andreuzzi B; Pini D; Gronda E
    Am Heart J; 2006 Feb; 151(2):477.e1-477.e6. PubMed ID: 16442917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors.
    Gasparini M; Regoli F; Ceriotti C; Galimberti P; Bragato R; De Vita S; Pini D; Andreuzzi B; Mangiavacchi M; Klersy C
    Am Heart J; 2008 Mar; 155(3):507-14. PubMed ID: 18294488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
    Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
    Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.